The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.

Resources

Communique of GTTAC meeting of 7 January 2021

This Communiqué covers matters considered at the 24th video conference of the Gene Technology Technical Advisory Committee (7 January 2021).

Documents

Communique of GTTAC meeting of 7 January 2021

This Communiqué covers matters considered at the 24th video conference of the Gene Technology Technical Advisory Committee (7 January 2021).

Download Communique of GTTAC meeting of 7 January 2021 as Word - 67.57 KB
Download Communique of GTTAC meeting of 7 January 2021 as PDF - 184.74 KB
Publication type:
Meeting communique
Publication date:
Description:

Licence application DIR 180 from AstraZeneca Pty Ltd is for the import, transport, storage and disposal of a genetically modified (GM) COVID-19 vaccine as part of its commercial supply as a vaccine in Australia. The Committee noted that the Therapeutic Goods Administration has regulatory responsibility for evaluating the efficacy of the vaccine and patient safety. 

Last updated: